Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Lamarca

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pulmonary Pharmacology & Therapeutics|August 6, 2018
Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort<sup>®</sup> (budesonide/formoterol) pressurized metered dose inhalerMichael Gillen, Pablo Forte, Jan Olof Svensson, et al.
Respiratory Medicine|August 28, 2023
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 studyYongchang Sun, Eduard Molins, Sami Z Daoud, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 4, 2017
Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years)David S Pearlman, Göran Eckerwall, Julie McLaren, et al.
The European Respiratory Journal|September 20, 2014
Characterisation and impact of reported and unreported exacerbations: results from ATTAINPaul W Jones, Rosa Lamarca, Ferran Chuecos, et al.
The European Respiratory Journal|March 24, 2012
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN studyPaul W Jones, Dave Singh, Eric D Bateman, et al.
The New England Journal of Medicine|May 17, 2018
Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2002
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAntònia Domingo-Salvany, Rosa Lamarca, Montserrat Ferrer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pulmonary Pharmacology & Therapeutics|August 6, 2018
Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort<sup>®</sup> (budesonide/formoterol) pressurized metered dose inhalerMichael Gillen, Pablo Forte, Jan Olof Svensson, et al.
Respiratory Medicine|August 28, 2023
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 studyYongchang Sun, Eduard Molins, Sami Z Daoud, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 4, 2017
Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years)David S Pearlman, Göran Eckerwall, Julie McLaren, et al.
The European Respiratory Journal|September 20, 2014
Characterisation and impact of reported and unreported exacerbations: results from ATTAINPaul W Jones, Rosa Lamarca, Ferran Chuecos, et al.
The European Respiratory Journal|March 24, 2012
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN studyPaul W Jones, Dave Singh, Eric D Bateman, et al.
The New England Journal of Medicine|May 17, 2018
Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2002
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAntònia Domingo-Salvany, Rosa Lamarca, Montserrat Ferrer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Pageof 3